Q1 2023 Evonik
Q1 adj. EBITDA of only €409 m due to low volumes and despite positive pricing in Specialties;
PA12 ramp-up driving Smart Materials, slow start in Specialty Additives, price pressure in Animal Nutrition and C4.
Positive pricing
in Specialties
despite low volumes.